The advisors’ recommendations follow news of ethically dubious gene-editing work carried out by He Jiankui late last year.

Uncertainties about the cells’ risk profiles and the potential for hyping unproven therapies mean scientists and the media must tread carefully.

After the controversy of a Chinese scientist who was involved in editing the genomes of twin girls, the country puts forth tighter guidelines.

Documents about the experiment challenge a Chinese government investigation’s finding that He Jiankui mostly acted alone.

Multiple researchers were aware of He Jiankui’s clinical trial before the news became public in November.

Researchers edited macaque embryos to induce symptoms of sleep disorders and chose one animal to clone. A bioethicist questions the study’s appropriateness.

A company announces the first pregnancy in a study of whether donor mitochondria can boost IVF’s odds of success.

The documentary weaves together a hunt for mammoth tusks in the Arctic with scenes from the front lines of synthetic biology.

2018 closed with hubbub surrounding the purported birth of babies whose genomes had been edited using CRISPR. What will 2019 hold for CRISPR’s use in humans?